Page last updated: 2024-11-07

dextroamphetamine and Nervous System Disorders

dextroamphetamine has been researched along with Nervous System Disorders in 7 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Research Excerpts

ExcerptRelevanceReference
"l-Ephedrine is an active ingredient in several herbal formulations with a mechanism of action similar to amphetamine and methamphetamine."1.31An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate. ( Bowyer, JF; Ferguson, SA; Gough, B; Newport, GD; Slikker, W; Tor-Agbidye, J, 2000)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fredriksson, A1
Archer, T1
Nadeau, SE1
Wu, SS1
Nudo, RJ1
Wojcik, BE1
Jinnah, HA1
Muller-Sieburg, CE1
Friedmann, T1
Bowyer, JF1
Newport, GD1
Slikker, W1
Gough, B1
Ferguson, SA1
Tor-Agbidye, J1
Schain, RJ1
Prabhu, VG1
Oester, YT1

Reviews

2 reviews available for dextroamphetamine and Nervous System Disorders

ArticleYear
Plasticity.
    NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, 2006, Volume: 3, Issue:4

    Topics: Combined Modality Therapy; Dextroamphetamine; Dopamine Uptake Inhibitors; Humans; Learning; Motor Co

2006
Minimal brain Dysfunction.
    Current problems in pediatrics, 1975, Volume: 5, Issue:10

    Topics: Attention Deficit Disorder with Hyperactivity; Brain Diseases; Cerebral Palsy; Child; Child, Prescho

1975

Other Studies

5 other studies available for dextroamphetamine and Nervous System Disorders

ArticleYear
Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.
    Neurotoxicity research, 2004, Volume: 6, Issue:6

    Topics: Animals; Animals, Newborn; Apoptosis; Attention Deficit Disorder with Hyperactivity; Central Nervous

2004
CIMT as a behavioral engine in research on physiological adjuvants to neurorehabilitation: the challenge of merging animal and human research.
    NeuroRehabilitation, 2006, Volume: 21, Issue:2

    Topics: Animals; Behavior Therapy; Central Nervous System Stimulants; Chemotherapy, Adjuvant; Cholinesterase

2006
Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT).
    Metabolic brain disease, 1999, Volume: 14, Issue:1

    Topics: Animals; Behavior, Animal; Bone Marrow Transplantation; Dextroamphetamine; Disease Models, Animal; D

1999
An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate.
    Toxicological sciences : an official journal of the Society of Toxicology, 2000, Volume: 55, Issue:1

    Topics: Animals; Caudate Nucleus; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; D

2000
Neuromuscular functions of mature mice following neonatal monosodium glutamate.
    Archives internationales de pharmacodynamie et de therapie, 1971, Volume: 189, Issue:1

    Topics: Animals; Animals, Newborn; Body Weight; Crowding; Dextroamphetamine; Female; Food Additives; Glutama

1971